Evidence map›Paper›PMID 33579805›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

Quantitative

Claudia Ortega, Rebecca K S Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu, Ur Metser

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Frontiers in endocrinology · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  6. Exploration of Chemokine Receptor 4 Targeted [Molecular imaging and biology · 2026
    Article
  7. Dual‑targeted radioligand therapy with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  8. Immune Checkpoint Blockade Enhances the Abscopal Effect of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  9. Review
  10. Article
  11. Normal organ [European journal of nuclear medicine and molecular imaging · 2026
    Article
  12. Effect of previousAnnals of nuclear medicine · 2026
    Article
  13. Article
  14. Article
  15. Prognostic value of interim [European radiology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Isolation of Peptide Ligands for the HIV Capsid Protein p24 by Phage-Display.International journal of peptide research and therapeutics · 2025
    Article
  20. Role ofFrontiers in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Claudia OrtegaJoint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Rebecca K S WongDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Josh SchaefferkoetterSiemens Medical Solutions USA, Inc., Knoxville, Tennessee.
Patrick Veit-HaibachJoint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Sten MyrehaugDivision of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Rosalyn JuergensDepartment of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
David LaidleyDivision of Nuclear Medicine, St. Joseph's Health Care London, University of Western Ontario, London, Ontario, Canada; and.
Reut AnconinaJoint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Amy LiuDepartment of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Ur MetserJoint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; ur.metser@uhn.ca.
University Health Network · CAJuravinski Cancer Centre · CAPrincess Margaret Cancer Centre · CASunnybrook Health Science Centre · CAUniversity of Toronto · CAWestern University · CAWomen's College Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to determine whether quantitative PET parameters on baseline

Indexed as

Neoplasm MetastasisNeuroendocrine TumorsOctreotideOrganometallic CompoundsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overDisease ProgressionFemaleHumansMaleMiddle AgedTreatment Outcomegallium Ga 68 dotatatelutetium Lu 177 dotatateOctreotideOrganometallic Compounds68Ga-DOTATATEneuroendocrine tumorsPET/CTPRRTresponsesurvival

Identifiers

PMID33579805
PMCPMC8724892
OpenAlexW3128650343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.